Pharmaceuticals Company Reports Improved Results For Fibromyalgia Treatment

Tonix Pharmaceuticals Reports Significant Improvement in Fibromyalgia Patients: A Look at the RESILIENT Phase 3 Clinical Trial.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

In a significant breakthrough for fibromyalgia patients, Tonix Pharmaceutic…